Thymus involvement in early‐onset myasthenia gravis

It has long been established that the thymus plays a central role in autoimmune myasthenia gravis (MG) because of either thymoma or thymic hyperplasia of lymphoproliferative origin. In this review, we discuss thymic changes associated with thymic hyperplasia and their implications in the development...

Full description

Saved in:
Bibliographic Details
Published inAnnals of the New York Academy of Sciences Vol. 1412; no. 1; pp. 137 - 145
Main Authors Cron, Mélanie A., Maillard, Solène, Villegas, José, Truffault, Frédérique, Sudres, Muriel, Dragin, Nadine, Berrih‐Aknin, Sonia, Panse, Rozen
Format Journal Article
LanguageEnglish
Published United States Wiley Subscription Services, Inc 01.01.2018
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:It has long been established that the thymus plays a central role in autoimmune myasthenia gravis (MG) because of either thymoma or thymic hyperplasia of lymphoproliferative origin. In this review, we discuss thymic changes associated with thymic hyperplasia and their implications in the development of an autoimmune response against the acetylcholine receptor (AChR).The hyperplastic MG thymus displays all the characteristics of tertiary lymphoid organs (TLOs): neoangiogenic processes with high endothelial venule and lymphatic vessel development, chemokine overexpression favoring peripheral cell recruitment, and ectopic germinal center development. As thymic epithelial cells or myoid cells express AChR, a specific antigen presentation can easily occur within the thymus in the presence of recruited peripheral cells, such as B cells and T follicular helper cells. How the thymus turns into a TLO is not known, but local inflammation seems mandatory. Interferon (IFN)‐β is overexpressed in MG thymus and could orchestrate thymic changes associated with MG. Knowledge about how IFN‐β is induced in MG thymus and why its expression is sustained even long after disease onset would be of interest in the future to better understand the etiological and physiopathological mechanisms involved in autoimmune MG.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:0077-8923
1749-6632
DOI:10.1111/nyas.13519